TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 34018057

Group type: EXPERIMENTAL
Intervention: Machine Learning (ML) using a random forest algorithm trained on 10 features extracted from ultrasound images.
Number of subjects: 201

Group type: EXPERIMENTAL
Intervention: Machine Learning (ML) aiding a breast radiologist.
Number of subjects: 201

Group type: COMPARATOR
Intervention: Breast radiologist without ML assistance.
Number of subjects: 201
Study: 34397282

Group type: EXPERIMENTAL
Intervention: Group A (1 RME activation per day)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Group B (2 RME activations per day)
Number of subjects: 26
Study: 33479844

Group type: COMPARATOR
Intervention: Bisphosphonates (BPs), predominantly alendronate, used by 9.4% of women and 1.5% of men.
Number of subjects: 28000

Group type: COMPARATOR
Intervention: Glucocorticoids
Number of subjects: 28000
Study: 35686864

Group type: EXPERIMENTAL
Intervention: Combined ultrasound guided peritendinous hyaluronic acid (HA) injection with extracorporeal shock waves therapy (E‐g)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Extracorporeal shock waves therapy only (SC‐g)
Number of subjects: 40
Study: 32472776

Group type: EXPERIMENTAL
Intervention: Fellow eye R
Number of subjects: 1960

Group type: EXPERIMENTAL
Intervention: Regression formula from group A
Number of subjects: 1960

Group type: EXPERIMENTAL
Intervention: Mean R from group A
Number of subjects: 1960
Study: 36175307

Group type: EXPERIMENTAL
Intervention: Enlarged lymph nodes in solid lesions
Number of subjects: 218

Group type: EXPERIMENTAL
Intervention: Enlarged lymph nodes in subsolid lesions
Number of subjects: 218

Group type: COMPARATOR
Intervention: Normal lymph nodes in control group
Number of subjects: 218
Study: 34023151

Group type: EXPERIMENTAL
Intervention: Physical activity (PA) participation
Number of subjects: 20806

Group type: EXPERIMENTAL
Intervention: Self-reported and accelerometer-based PA phenotypes
Number of subjects: 20806
Study: 34394697

Group type: EXPERIMENTAL
Intervention: Richmond agitation and sedation scale
Number of subjects: 74
Study: 33616478

Group type: EXPERIMENTAL
Intervention: HL02 (6 mg/kg)
Number of subjects: 107

Group type: COMPARATOR
Intervention: US-trastuzumab
Number of subjects: 107

Group type: EXPERIMENTAL
Intervention: HL02
Number of subjects: 107

Group type: EXPERIMENTAL
Intervention: Both HL02 and US-trastuzumab
Number of subjects: 107

Group type: EXPERIMENTAL
Intervention: HL02 and US-trastuzumab
Number of subjects: 107
Study: 33140994

Group type: EXPERIMENTAL
Intervention: TAU plus a digital therapeutic (67 digital, interactive educational modules)
Number of subjects: 170

Group type: COMPARATOR
Intervention: TAU (treatment-as-usual)
Number of subjects: 170

Group type: EXPERIMENTAL
Intervention: TAU plus a digital therapeutic
Number of subjects: 170

Group type: COMPARATOR
Intervention: TAU
Number of subjects: 170
Study: 34730863

Group type: EXPERIMENTAL
Intervention: Real iTBS (intermittent theta burst stimulation)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Sham iTBS
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Real iTBS
Number of subjects: 22
Study: 32640924

Group type: EXPERIMENTAL
Intervention: Exposure to cyberterrorism
Number of subjects: 0
Study: 36097996

Group type: EXPERIMENTAL
Intervention: Quarterly screening
Number of subjects: 8240

Group type: COMPARATOR
Intervention: Annual screening
Number of subjects: 8240

Group type: EXPERIMENTAL
Intervention: Quarterly screening plus
Number of subjects: 8240
Study: 32541301

Group type: EXPERIMENTAL
Intervention: Tissue Anchoring System (TAS)
Number of subjects: 99

Group type: COMPARATOR
Intervention: Traditional SSLF
Number of subjects: 99
Study: 32422942

Group type: EXPERIMENTAL
Intervention: UDCA treatment (100 mg three times per day for two months)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Untreated group (monitored for two months without intervention)
Number of subjects: 24
Study: 34919774

Group type: EXPERIMENTAL
Intervention: High-Intensity Interval Training (HIIT) based on playground games (MOVI-daFit!)
Number of subjects: 562
Study: 33044102

Group type: EXPERIMENTAL
Intervention: Acarbose test formulation (T)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control (R)
Number of subjects: 12
Study: 33883024

Group type: EXPERIMENTAL
Intervention: Enhanced PeriOperative Care and Health Protection programme (EPO2CH)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: EPO2CH
Number of subjects: 0
Study: 33683313

Group type: EXPERIMENTAL
Intervention: Intensive treatment (systolic blood pressure goal <120 mm Hg)
Number of subjects: 673

Group type: COMPARATOR
Intervention: Standard treatment (systolic blood pressure goal <140 mm Hg)
Number of subjects: 673

Group type: COMPARATOR
Intervention: Comparison between intensive and standard treatment
Number of subjects: 673

Group type: EXPERIMENTAL
Intervention: Intensive treatment
Number of subjects: 673
Study: 36229224

Group type: COMPARATOR
Intervention: Recombinant human erythropoietin (rhEpo) treatment, 9 IU × kg bw−1, injected three times per week for 4 weeks
Number of subjects: 0

Group type: COMPARATOR
Intervention: Blood transfusions, 130 ml red blood cells infused
Number of subjects: 0
Study: 32612251

Group type: EXPERIMENTAL
Intervention: Engage therapy
Number of subjects: 249

Group type: COMPARATOR
Intervention: Problem-Solving Therapy (PST)
Number of subjects: 249
Study: 34042388

Group type: EXPERIMENTAL
Intervention: 6 weeks of antibiotic therapy
Number of subjects: 410

Group type: COMPARATOR
Intervention: 12 weeks of antibiotic therapy
Number of subjects: 410
Study: 32533622

Group type: EXPERIMENTAL
Intervention: Intervention group (early follow-up in a preventive clinic within 1 week)
Number of subjects: 73

Group type: COMPARATOR
Intervention: Control group (standard care)
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: Intervention group
Number of subjects: 73

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 73
Study: 34409654

Group type: EXPERIMENTAL
Intervention: Vedolizumab with concomitant immunomodulator use
Number of subjects: 0

Group type: COMPARATOR
Intervention: Vedolizumab without concomitant immunomodulator use
Number of subjects: 0
Study: 33962841

Group type: EXPERIMENTAL
Intervention: NDV-3A vaccine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo (adjuvant alone)
Number of subjects: 0
Study: 35068168

Group type: EXPERIMENTAL
Intervention: Apomorphine sublingual film (APL)
Number of subjects: 0
Study: 33813244

Group type: EXPERIMENTAL
Intervention: 10 g of sucrose (S10)
Number of subjects: 59

Group type: COMPARATOR
Intervention: 15 g of sucrose (S15)
Number of subjects: 59
Study: 35997816

Group type: EXPERIMENTAL
Intervention: NAVIGATE (Early Intervention Services)
Number of subjects: 0

Group type: COMPARATOR
Intervention: CC (Usual Community Care)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: NAVIGATE
Number of subjects: 0
Study: 32205557

Group type: EXPERIMENTAL
Intervention: Perineorrhaphy
Number of subjects: 46

Group type: COMPARATOR
Intervention: No perineorrhaphy
Number of subjects: 46
Study: 32173628

Group type: EXPERIMENTAL
Intervention: Decision aid
Number of subjects: 324

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 324
Study: 33026570

Group type: EXPERIMENTAL
Intervention: Masturbation (at least 3–4 times a week)
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: Tamsulosin 0.4 mg/day
Number of subjects: 128

Group type: COMPARATOR
Intervention: Standard medical therapy alone (Control)
Number of subjects: 128
Study: 32390170

Group type: EXPERIMENTAL
Intervention: Guided tissue regeneration (GTR) therapy
Number of subjects: 50
Study: 36356631

Group type: EXPERIMENTAL
Intervention: High-intensity care
Number of subjects: 1078

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 1078
Study: 34596572

Group type: EXPERIMENTAL
Intervention: Digital human intervention involving cognitive behavioral and positive psychology exercises for at least 15 minutes per day over 1 week.
Number of subjects: 30

Group type: COMPARATOR
Intervention: Waitlist control group that received the intervention 1 week later.
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Digital human intervention
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Trial methods
Number of subjects: 30
Study: 35064876

Group type: EXPERIMENTAL
Intervention: Subjective titration
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: PSG-guided titration using RCMP
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: DISE-assisted titration using RCMP
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control (maximal comfortable protrusion)
Number of subjects: 10
Study: 33713213

Group type: EXPERIMENTAL
Intervention: Dapivirine vaginal ring (DVR)
Number of subjects: 2334
Study: 36416823

Group type: EXPERIMENTAL
Intervention: Intermittent pulse oximetry (every 4 hours)
Number of subjects: 229

Group type: COMPARATOR
Intervention: Continuous pulse oximetry
Number of subjects: 229
Study: 32011942

Group type: EXPERIMENTAL
Intervention: Individualized Management for Patient‐Centered Targets (IMPaCT)
Number of subjects: 0
Study: 36120593

Group type: EXPERIMENTAL
Intervention: OEA 300 mg/day
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: OEA 600 mg/day
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 32776357

Group type: EXPERIMENTAL
Intervention: Sacubitril/valsartan
Number of subjects: 37790
Study: 32908282

Group type: EXPERIMENTAL
Intervention: AI-DSS arm (n = 54)
Number of subjects: 108

Group type: COMPARATOR
Intervention: Physician arm (n = 54)
Number of subjects: 108
Study: 34498388

Group type: EXPERIMENTAL
Intervention: BISO/RAMI 10/5 mg
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: BISO/RAMI 10/10 mg
Number of subjects: 64

Group type: COMPARATOR
Intervention: BISO 10 mg and RAMI 10 mg (single doses)
Number of subjects: 64
Study: 33928903

Group type: EXPERIMENTAL
Intervention: Tranexamic acid (loading dose 1 g over 10 minutes then infusion of 1 g over 8 hours)
Number of subjects: 9127

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9127

Group type: EXPERIMENTAL
Intervention: Tranexamic acid
Number of subjects: 9127
Study: 34645170

Group type: EXPERIMENTAL
Intervention: CRS+HIPEC
Number of subjects: 781
Study: 32529206

Group type: EXPERIMENTAL
Intervention: Oily fish (∼300 g/wk)
Number of subjects: 199

Group type: COMPARATOR
Intervention: Poultry (control)
Number of subjects: 199
Study: 33808030

Group type: EXPERIMENTAL
Intervention: Elimination/reducing diets (Group A, n=50)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Reducing diets with the same caloric content (Group B, n=50)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Elimination/reducing diets (Group A)
Number of subjects: 100
Study: 34717041

Group type: EXPERIMENTAL
Intervention: givosiran (2.5 mg/kg monthly)
Number of subjects: 94

Group type: COMPARATOR
Intervention: placebo (during double-blind period)
Number of subjects: 94
Study: 34023513

Group type: EXPERIMENTAL
Intervention: Tofacitinib (TOF group)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Control (CON group)
Number of subjects: 62
Study: 33052789

Group type: EXPERIMENTAL
Intervention: Topical scar gel containing Allium cepa extract, allantoin and heparin, applied postoperatively for 6 months.
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 120
Study: 35259918

Group type: EXPERIMENTAL
Intervention: Invasive treatment strategy (INV)
Number of subjects: 1819

Group type: COMPARATOR
Intervention: Conservative strategy
Number of subjects: 1819

Group type: EXPERIMENTAL
Intervention: Both INV and Conservative strategy
Number of subjects: 1819
Study: 34693701

Group type: EXPERIMENTAL
Intervention: N-acetylcysteine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Melatonin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study: 35292055

Group type: EXPERIMENTAL
Intervention: Qingre Lishi Decoction (QLRD) - 'heat-clearing and diuresis-promoting' prescription
Number of subjects: 78

Group type: COMPARATOR
Intervention: Basic treatment and colchicine tablets (Control)
Number of subjects: 78
Study: 34555158

Group type: EXPERIMENTAL
Intervention: Point-of-care testing (POCT) in the ED
Number of subjects: 474

Group type: COMPARATOR
Intervention: Central laboratory testing
Number of subjects: 474
Study: 32990768

Group type: EXPERIMENTAL
Intervention: Contingency management
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 35452654

Group type: EXPERIMENTAL
Intervention: Angle of progression measurement communicated to obstetrician
Number of subjects: 45

Group type: COMPARATOR
Intervention: Standard digital examination without angle of progression measurement
Number of subjects: 45
Study: 34686108

Group type: EXPERIMENTAL
Intervention: Test-coached simulators
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Sophisticated simulators
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Naïve simulators
Number of subjects: 80

Group type: COMPARATOR
Intervention: Honest responding control group
Number of subjects: 80
Study: 35501215

Group type: EXPERIMENTAL
Intervention: 25% dextrose solution
Number of subjects: 30

Group type: COMPARATOR
Intervention: Normal saline
Number of subjects: 30
Study: 32272976

Group type: EXPERIMENTAL
Intervention: EQ-5D-5L
Number of subjects: 648

Group type: COMPARATOR
Intervention: EQ-5D-3L
Number of subjects: 648
Study: 35088613

Group type: EXPERIMENTAL
Intervention: Online Learning Modules Strategy (OLMS)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 68
Study: 34813986

Group type: EXPERIMENTAL
Intervention: Fully Integrated Treatment (FIT) for comorbid SAD and AUD IOP
Number of subjects: 56

Group type: COMPARATOR
Intervention: Usual Care (UC) consisting of the evidence-based Matrix Model of Addiction IOP
Number of subjects: 56
Study: 32188442

Group type: EXPERIMENTAL
Intervention: Pfmsp‐2 loci
Number of subjects: 350

Group type: EXPERIMENTAL
Intervention: Pfmsp‐1
Number of subjects: 350

Group type: EXPERIMENTAL
Intervention: Pfmsp‐2
Number of subjects: 350

Group type: EXPERIMENTAL
Intervention: K1 and MAD20 of Pfmsp1 allelic variant
Number of subjects: 350
Study: 33789524

Group type: EXPERIMENTAL
Intervention: H1-receptor antagonists (H1RAs)
Number of subjects: 51
Study: 35049172

Group type: EXPERIMENTAL
Intervention: Respiratory Muscle Training (RMT)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control Group
Number of subjects: 40
Study: 33091192

Group type: EXPERIMENTAL
Intervention: On-demand inhaled interferon beta-1a (AZD9412)
Number of subjects: 121

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 121
Study: 35872235

Group type: EXPERIMENTAL
Intervention: IVPCA (Intravenous Patient-Controlled Analgesia)
Number of subjects: 99

Group type: COMPARATOR
Intervention: On-demand administration (oral, intramuscular, or intravenous)
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 99
Study: 34006544

Group type: EXPERIMENTAL
Intervention: Cochlear implantation
Number of subjects: 50

Group type: COMPARATOR
Intervention: No intervention (control group)
Number of subjects: 50
Study: 33657029

Group type: EXPERIMENTAL
Intervention: OT100 online course (n = 74)
Number of subjects: 198

Group type: EXPERIMENTAL
Intervention: OT100 traditional course (n = 59)
Number of subjects: 198

Group type: COMPARATOR
Intervention: PT100 control course (n = 65)
Number of subjects: 198
Study: 33105390

Group type: EXPERIMENTAL
Intervention: BFR alone
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: BFR + EMS
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control (CON)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: BFR
Number of subjects: 30
Study: 32563290

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 36345827

Group type: EXPERIMENTAL
Intervention: 0.07% cetylpyridinium chloride (CPC) mouthwash
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo mouthwash
Number of subjects: 80
Study: 35679576

Group type: EXPERIMENTAL
Intervention: Web-based decision aid combined with standard educational materials
Number of subjects: 282

Group type: COMPARATOR
Intervention: Standard educational materials alone
Number of subjects: 282
Study: 33150559

Group type: EXPERIMENTAL
Intervention: Periodontal disease (measured by probing pocket depth, PPD)
Number of subjects: 490

Group type: EXPERIMENTAL
Intervention: Proportion of teeth with PPD ≥ 4 mm
Number of subjects: 490
Study: 32396189

Group type: COMPARATOR
Intervention: SGTF-U
Number of subjects: 332

Group type: EXPERIMENTAL
Intervention: SGTF-T
Number of subjects: 332
Study: 33739913

Group type: EXPERIMENTAL
Intervention: Cyber-ostracized group (n=66)
Number of subjects: 145

Group type: COMPARATOR
Intervention: Cyber-included group (n=79)
Number of subjects: 145
Study: 34183341

Group type: EXPERIMENTAL
Intervention: TRiP(cast) score based thromboprophylactic anticoagulant treatment for patients with a score ≥7
Number of subjects: 0

Group type: COMPARATOR
Intervention: Current practice of thromboprophylaxis
Number of subjects: 0
Study: 33313733

Group type: EXPERIMENTAL
Intervention: IVR CBT‐CP
Number of subjects: 764

Group type: COMPARATOR
Intervention: Synchronous CBT‐CP
Number of subjects: 764
Study: 34392382

Group type: EXPERIMENTAL
Intervention: Imageless robotic-assisted total knee arthroplasty (RATKA)
Number of subjects: 152

Group type: COMPARATOR
Intervention: Conventional total knee arthroplasty (TKA)
Number of subjects: 152
Study: 35819423

Group type: EXPERIMENTAL
Intervention: Pharmacogenomic-guided treatment (n=966)
Number of subjects: 1944

Group type: COMPARATOR
Intervention: Usual care (n=978)
Number of subjects: 1944

Group type: EXPERIMENTAL
Intervention: Pharmacogenomic-guided treatment
Number of subjects: 1944

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 1944
Study: 33743753

Group type: EXPERIMENTAL
Intervention: North American sites
Number of subjects: 602

Group type: EXPERIMENTAL
Intervention: International sites
Number of subjects: 602

Group type: EXPERIMENTAL
Intervention: Sites with research personnel
Number of subjects: 602

Group type: EXPERIMENTAL
Intervention: Sites without research support
Number of subjects: 602

Group type: EXPERIMENTAL
Intervention: Publicly funded sites
Number of subjects: 602

Group type: EXPERIMENTAL
Intervention: Privately funded sites
Number of subjects: 602
Study: 32802039

Group type: EXPERIMENTAL
Intervention: Transcutaneous auricular vagus nerve stimulation (taVNS)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Sham taVNS
Number of subjects: 21
Study: 36100350

Group type: EXPERIMENTAL
Intervention: Open-label ixekizumab (OL IXE) retreatment after flare
Number of subjects: 155

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 155

Group type: EXPERIMENTAL
Intervention: Continuous ixekizumab treatment
Number of subjects: 155
Study: 33899259

Group type: EXPERIMENTAL
Intervention: Group-A (a-BMMSCs + collagen scaffold + aFPL)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Group-B (collagen scaffold + aFPL without a-BMMSCs)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Group-C (Minimal Access Flap surgery)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Group-A and Group-C
Number of subjects: 27
Study: 32631400

Group type: EXPERIMENTAL
Intervention: Full intervention (interactive educational video, telecare phone call from a nurse, electronic communication to primary care provider)
Number of subjects: 360

Group type: EXPERIMENTAL
Intervention: Video-only intervention (interactive educational video only)
Number of subjects: 360

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 360

Group type: EXPERIMENTAL
Intervention: Full intervention
Number of subjects: 360

Group type: EXPERIMENTAL
Intervention: Video-only intervention
Number of subjects: 360
Study: 36126151

Group type: EXPERIMENTAL
Intervention: Supervised sprint interval training (SIT) for 12 weeks, 4-6 × 30s cycling bouts, 3 days a week
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Supervised sprint interval training (SIT) for 12 weeks
Number of subjects: 28

Group type: COMPARATOR
Intervention: Control group (CONT)
Number of subjects: 28
Study: 34747132

Group type: EXPERIMENTAL
Intervention: Empathic communication style
Number of subjects: 136
Study: 34750069

Group type: COMPARATOR
Intervention: Control group (HT0)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Once per week heat training (HT1)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Twice per week heat training (HT2)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Heat acclimatization and heat acclimation (HAz+HA)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Heat training (HT)
Number of subjects: 24
Study: 34271551

Group type: EXPERIMENTAL
Intervention: Home-based exercise program
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 100
Study: 32635999

Group type: EXPERIMENTAL
Intervention: Minimalist footwear (Moleca®)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Regular clinical treatment for OA
Number of subjects: 56
Study: 36232016

Group type: EXPERIMENTAL
Intervention: Anodal transcranial direct current stimulation (tDCS) for 20 minutes, applied to the left dorsolateral prefrontal cortex (F7) with the cathode on the right supraorbital area (Fp2)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Sham stimulation (control group)
Number of subjects: 31
Study: 34975131

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine 0.75 μg/kg intravenous over 10 min
Number of subjects: 48

Group type: COMPARATOR
Intervention: Midazolam 0.035 mg/kg intravenous over 1 min
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine
Number of subjects: 48

Group type: COMPARATOR
Intervention: Midazolam
Number of subjects: 48
Study: 35150184

Group type: EXPERIMENTAL
Intervention: LUMIVIVE® System (LVS) plus basic moisturizer
Number of subjects: 100

Group type: COMPARATOR
Intervention: basic moisturizer
Number of subjects: 100
Study: 32892665

Group type: EXPERIMENTAL
Intervention: Metformin
Number of subjects: 10000

Group type: COMPARATOR
Intervention: No intervention
Number of subjects: 10000
Study: 32836201

Group type: EXPERIMENTAL
Intervention: Nomogram for predicting overall survival (OS)
Number of subjects: 2263
Study: 35085506

Group type: EXPERIMENTAL
Intervention: Pyrotinib 400 mg orally once daily and capecitabine 1000 mg/m2 orally twice daily for 14 days, followed by 7 days off every 3 weeks until disease progression or unacceptable toxicity.
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Pyrotinib plus capecitabine
Number of subjects: 78
Study: 33689903

Group type: COMPARATOR
Intervention: Control group (CTRL): multiple unidirectional FRC-post + dual-cure composite-core
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: PFC: multiple unidirectional FRC-post + packable short fiber-reinforced composite (SFRC)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: BPFC: Bioblock technique with only packable SFRC
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: BFFC: Bioblock technique with only flowable SFRC
Number of subjects: 60